News about Global Pharma

Daewoong Pharma, Hanall Biopharma expand global collaboration initiative by investing in Boston-based Alloplex Biotherapeutics

Daewoong Pharmaceutical and Hanall Biopharma of South Korea are expanding their global open collaboration initiative by investing in Alloplex Biotherapeutics, an emerging biotechnology company based in Boston

Global Pharma | 21/08/2021 | By Darshana |  269

US FDA approves Roche's companion diagnostic test, Ventana MMR RxDx Panel to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy

Roche announced US Food and Drug Administration (FDA) approval of the Ventana MMR RxDx Panel, advancing the company's commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies

Global Pharma | 20/08/2021 | By Darshana |  417

Pfizer and BioNTech submit phase I data to US FDA to support booster dose of Covid-19 vaccine

Pfizer and BioNTech announced that they have submitted phase 1 data to the US Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies' Covid-19 vaccine (BNT162b2) for future licensure

Global Pharma | 18/08/2021 | By Darshana |  191

BioReference Labs buys US Ariosa centralized laboratory prenatal testing business from Roche

BioReference Laboratories, Inc., an OPKO Health company announced the acquisition of the US Ariosa centralized laboratory prenatal testing business from Roche.

Global Pharma | 18/08/2021 | By Darshana |  320

Health Gorilla, Ambra Health ink partnership for seamless digital medical imaging

Ambra Health, maker of the leading cloud-based, medical image management suite, and Health Gorilla, the leading provider of healthcare APIs, announced a partnership to enable medical image viewing directly within Health Gorilla's platform

Global Pharma | 09/08/2021 | By Darshana |  180

Ispen, Exicure ink collaboration to research, develop and commercialize spherical nucleic acids for Huntington's disease & Angelman syndrome

Ipsen and Exicure have signed an exclusive collaboration agreement to research, develop, and commercialize novel spherical nucleic acids (SNAs) as potential investigational treatments for Huntington's disease and Angelman syndrome

Global Pharma | 03/08/2021 | By Darshana |  227

AbbVie, Calico Life extend partnership to discover & develop new therapies

AbbVie and Calico Life Sciences announced an extension of their leading-edge collaboration to discover, develop and bring to market new therapies for patients with age-related diseases, including neurodegeneration and cancer. This is the second extension of the collaboration originally established in 2014

Global Pharma | 29/07/2021 | By Darshana |  396

AstraZeneca completes acquisition of Alexion Pharmaceuticals

AstraZeneca completed the acquisition of Alexion Pharmaceuticals, (Alexion). The closing of the acquisition marks the company's entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca

Global Pharma | 23/07/2021 | By Darshana |  277

US FDA approves Merck's Vaxneuvance for prevention of invasive pneumococcal disease

Vaxneuvance is contraindicated for individuals with a history of severe allergic reaction (e.g., anaphylaxis) to any component of Vaxneuvance or to diphtheria toxoid; see additional Select Safety Information below

Global Pharma | 19/07/2021 | By Darshana |  385

Stallergenes Greer, Alyatec enter research collaboration to advance precision medicine in allergen immunotherapy

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), and Alyatec, a contract research organisation based in Strasbourg University Hospital (France), announced that they have entered into a collaboration to advance precision medicine in AIT

Global Pharma | 12/07/2021 | By Darshana |  172